Patrick Eagan Net Worth

What's Patrick Eagan's mailing address?

Patrick's mailing address filed with the SEC is 400 Interpace Pkwy, Parsippany, NJ 07054, USA.

Insiders trading at Enact Inc

Over the last 12 years, insiders at Enact Inc have traded over $742,398,702 worth of Enact Inc stock and bought 189,956 units worth $3,738,670 . The most active insiders traders include Holdings, Inc. Genworth, Daniel J Iv Sheehan et Michael A Bless. On average, Enact Inc executives and independent directors trade stock every 60 days with the average trade being worth of $19,061,714. The most recent stock trade was executed by Holdings, Inc. Genworth on 30 August 2024, trading 697,093 units of ACT stock currently worth $23,401,412.

What does Enact Inc do?

Enact Holdings, Inc. operates as a holding company. Through its subsidiaries, Enact provides mortgage insurance services to mortgage lenders and investors.

Enact Inc executives and stock owners

Enact Inc executives and other stock owners filed with the SEC include:

• Rohit Gupta,
  Pres, CEO & Director
• Hardin Dean Mitchell,
  EVP, CFO & Treasurer
• Evan Scott Stolove,
  Exec. VP, Gen. Counsel & Sec.
• Piotr Bielinski,
  Chairman of the Management Board
• Slawomir Harazin,
  Vice Chairman of the Management Board
• Iwona Bocianowska,
  Chairwoman of the Supervisory Board
• Krzysztof Kaczmarczyk,
  Member of the Supervisory Board
• Piotr Chajderowski,
  Independent Member of the Supervisory Board
• Marek Jakubowski,
  Secretary of the Supervisory Board
• Adam Switalski,
  Independent Vice Chairman of the Supervisory Board
• Anna Bielinska,
  Director of Public Relations and Investor Relations
• Andrzej Bialy,
  Finance Director
• James Robert McMullen,
  Controller
• Michael Paul Derstine,
  Exec. VP & Chief Risk Officer
• Brian Michael Gould,
  EVP & COO
• Rohit Gupta,
  President and CEO
• Brian Gould,
  EVP & Chief Operations Officer
• James Mc Mullen,
  Controller
• Hardin Dean Mitchell,
  EVP, CFO and Treasurer
• Evan Stolove,
  EVP, Gen. Counsel & Secretary
• Michael Derstine,
  EVP and Chief Risk Officer
• Fred G Weiss,
  Director
• Ronald R Taylor,
  Director
• Jack Michelson,
  Director
• Cathy Klema,
  Director
• Andrew L Turner,
  Director
• Albert F Hummel,
  Director
• Michael J Fedida,
  Director
• George Fred Wilkinson,
  Pres-Global Brands&Biosimilars
• Michel J Feldman,
  Director
• R Todd Joyce,
  CFO-Global & PAO
• Sigurdur O Olafsson,
  Pres-Global Generics
• Chris W Bodine,
  Director
• Robert A Stewart,
  Pres-Global Operations
• Albert Iii Paonessa,
  President of Anda, Inc.
• Charles M Mayr,
  Chief Communic Off-Global
• Charles D Ebert,
  Sr. VP, Research & Development
• David A Buchen,
  Chief Legal Officer-Global&Sec
• Hafrun Fridriksdottir,
  Sr VP,Global Generics R&D
• Patrick Eagan,
  Chief HR Officer - Global
• Paul Bisaro,
  President & CEO
• Dominic James Addesso,
  Director
• Robert P Jr Restrepo,
  Director
• John D Fisk,
  Director
• Anne G Waleski,
  Director
• Westley V Thompson,
  Director
• Daniel J Iv Sheehan,
  Director
• Debra Still,
  Director
• Holdings, Inc. Genworth,
  
• Michael A Bless,
  Director
• Raymond T Odierno,
  Director
• Sheila Hooda,
  Director